In published research, this triple-receptor profile is associated with the largest reductions in body weight of the three compounds under study
In this combined analysis, we observe that the degree of BMI loss depends strongly on sex, drug type, time on treatment and drug dosage, consistent with previous reports 11 , and has a relatively weak dependence on pre-treatment BMI (with higher starting BMI associated with greater BMI loss)
Retrieved from Liao, C., Liang, X., Zhang, X., et al
The 2 major incretins found in the body are gastric-inhibitory-polypeptide (GIP) and glucagon-like-peptide-1 (GLP-1) [2]
Altered baseline brain activity in children with ADHD revealed by resting-state functional MRI
GLP-1s are being studied with once-weekly and once-daily dosing options, which may offer convenience and flexibility for patients